WBI Investments’s Boston Scientific BSX Stock Holding History

WBI Investments’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-28,876	Closed	-$2.22M	–	233
2024 Q2	$2.22M	Buy	+28,876	New	+$2.11M	0.54%	55

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

WBI Investments's BSX Position: Q3 2024 in Review

WBI Investments sold out of Boston Scientific (BSX) in Q3 2024, closing a stake of 28,876 shares — an estimated $2.22M sold.

WBI Investments first reported a position in BSX in Q2 2024 and held it in 1 quarter. The position peaked at $2.22M in Q2 2024. 1,395 funds tracked by Wall St. Rank hold BSX as of Q3 2024.

WBI Investments reported no remaining Boston Scientific position as of Q3 2024 after selling out during the quarter.
WBI Investments sold 28,876 Boston Scientific shares in Q3 2024, an estimated $2.22M.
WBI Investments first reported a position in Boston Scientific in Q2 2024 and held it in 1 quarter.
WBI Investments's Boston Scientific position peaked at $2.22M in Q2 2024.
1,395 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2024.

Based on WBI Investments's 13F filing for Q3 2024, filed 12 Nov 2024.